Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT5A | Q9NQR1 | 1/20 | 0.46 |
| ▸ | GBA1 | P04062 | 7/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CRHBP | P24387 | 1/20 | 0.39 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1091507 | 0.87 | SMN1; SMN2 (0.54) | SMN1; SMN2MAPK1KMT2ALMNAMEN1 | |
| SCHEMBL13625149 | 0.83 | SMN1; SMN2 (0.58) | SMN1; SMN2MAPK1KMT2ALMNAMEN1 | |
| SCHEMBL778367 | 0.83 | TSHR (0.59) | SMN1; SMN2MAPK1KMT2ALMNAMEN1 | |
| SCHEMBL12373451 | 0.79 | KMT2A (0.57) | KMT2ALMNA | |
| SCHEMBL28769756 | 0.78 | LMNA (0.67) | SMN1; SMN2KMT2ALMNAMEN1GBA1 | |
| SCHEMBL4132657 | 0.77 | LMNA (0.76) | SMN1; SMN2KMT2ALMNAMEN1GBA1 | |
| SCHEMBL21325620 | 0.77 | LMNA (0.57) | SMN1; SMN2KMT2ALMNAMEN1GBA1 | |
| SCHEMBL21325794 | 0.76 | LMNA (0.55) | SMN1; SMN2KMT2ALMNAMEN1GBA1 | |
| SCHEMBL8050942 | 0.76 | LMNA (0.69) | SMN1; SMN2KMT2ALMNAMEN1GBA1 | |
| SCHEMBL21325621 | 0.75 | LMNA (0.58) | SMN1; SMN2KMT2ALMNAMEN1GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150057395-A1 | Polytriazinyl Compounds as Flame Retardants and Light Stabilizers | MCA TECHNOLOGIES GMBH (CH) | 2015-02-26 | — | — | US | disclosed |
| US-20140011923-A1 | Polytriazinyl Compounds as Flame Retardants and Light Stabilizers | MCA TECHNOLOGIES GMBH (CH) | 2014-01-09 | — | — | US | disclosed |
| US-20120245291-A1 | Polytriazinyl Compounds as Flame Retardants and Light Stabilizers | MCA TECHNOLOGIES GMBH (CH) | 2012-09-27 | — | — | US | disclosed |
| US-8202924-B2 | Polytriazinyl compounds as flame retardants and light stabilizers | MCA TECHNOLOGIES GMBH (CH) | 2012-06-19 | — | — | US | disclosed |
| US-20120071594-A1 | POLYTRIAZINYL COMPOUNDS AS FLAME RETARDANTS AND LIGHT STABILIZERS | MCA TECHNOLOGIES GMBH (CH) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071594-A1 | POLYTRIAZINYL COMPOUNDS AS FLAME RETARDANTS AND LIGHT STABILIZERS | PCBP1, PBRM1, TAF5 | SMN1; SMN2 2588/4885MAPK1 2095/4885KMT2A 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.